3SBio Inc.

3SBio Inc.
Stock Exchange Hong Kong Stock Exchange
EPS
HKD0.58
Market Cap
HKD35.68 B
Shares Outstanding
2.53 B
Public Float
1.25 B

Profile

Address
Shenyang Economy & Tech Development
Shenyang Liaoning 110027
China
Employees -
Website http://www.3sbio.com
Updated 07/08/2019
3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products. It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.

Financials

View All
Created with Highcharts 5.0.143SBio Inc.Net Income. Fiscal year is January-December. All values HKD Millions.1211213673676496498338331 0791 0791 5131 5132013201420152016201720180500100015002000
Created with Highcharts 5.0.143SBio Inc.Sales/Revenue. Fiscal year is January-December. All values HKD Millions.1 1051 1051 4231 4232 0642 0643 2683 2684 3064 3065 4295 42920132014201520162017201801k2k3k4k5k6k

Jing Lou
Chairman, President & Chief Executive Officer
Bo Tan
Chief Financial Officer, Executive Director & EVP